Pfizer CEO says omicron vaccine will be ready in March
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
Covid-19 testing in the time of omicron: Everything you need to know